Trademark: BioSenic 2352037
Word
BioSenic
ID
2352037
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
14 March 2023
Registration Date
14 March 2023
Renewal Date
14 March 2033
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations; medical preparations; biotechnological preparations for medical use; chemical preparations for medical use; chemical preparations for pharmaceutical use; pharmaceutical implants; biological implants; implants comprising living tissue; cell, gene and protein-based therapy products for treating and preventing musculoskeletal indications and inflammatory related diseases; pharmaceutical products for the treatment of bone diseases or disorders and inflammatory related diseases; bone-forming cells for bone fracture repair, fracture prevention and bone fusion; cell therapy products for the treatment of bone diseases or disorders; allogeneic osteoblastic cell therapy products; tissue and bone-regenerative pharmaceutical preparations; biological tissue cultures for medical purposes; natural biomaterials for augmentation of bone and tissue for medical purposes; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, bone diseases and disorders.
Pharmaceutical preparations; medical preparations; biotechnological preparations for medical use; chemical preparations for medical use; chemical preparations for pharmaceutical use; pharmaceutical implants; biological implants; implants comprising living tissue; cell, gene and protein-based therapy products for treating and preventing musculoskeletal indications and inflammatory related diseases; pharmaceutical products for the treatment of bone diseases or disorders and inflammatory related diseases; bone-forming cells for bone fracture repair, fracture prevention and bone fusion; cell therapy products for the treatment of bone diseases or disorders; allogeneic osteoblastic cell therapy products; tissue and bone-regenerative pharmaceutical preparations; biological tissue cultures for medical purposes; natural biomaterials for augmentation of bone and tissue for medical purposes; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, bone diseases and disorders.